Screenshot
Presentation
The Cohort Definition module allows you to define the scope of the analysis you want to perform:
The Market / product including the choice of WHO ATC class and / or product code and / or brand…
Co-treatments with the possibility of including or excluding patients who have received, in addition, products belonging to selected WHO ATC classes
The Demographic Profile using patient age and gender variables
The Period including the choice of the regularity of pharmacy visits* and the selection of the analysis period (closed or open cohort)
* The regularity of the visits corresponds to the maximum time desired between 2 visits to the pharmacy (whatever the product dispensed) . Beyond this period, patients will be excluded from the analysis
Ex: if the regularity of visits is set at 3 months, each patient must return to the pharmacy at least every 3 months over the entire analysis period in order to be included.
Data sources
Patient Data
Geographic territories
NA
Market
NA
Status
Subscription
Patient Analytics
Objects present in the sheet
WHO ATC classification level selector
WHO ATC class selector
Product selector (Code, label)
Product code selection text box
Active ingredient selector
Generic / original drug selector
Laboratory selector
Brand selector
CQCP (product qualifications) selectors
co-treatment button
Gender selector
Age group type selector
Age group selector
Slider for selecting the regularity of visits
Analysis period selector
Explanatory graph of analysis period
Navigation button to the visualization of the cohort
Delete selections button
Indicators
NA
Options
NA
Versions
Current version:
Added selectors for CQCP
Old versions:
Update of the traceability cartridge
Modification of the analysis period (addition of a period at the end of the inclusion)
Variabilisation
Addition of co-treatments
New specification
Limitations
NA